Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-04-02 | Dr. Kevin LeeCEO & Executive Director | -7,68k | 37,96k | Vendita | 4,91 - 5,05 | 317,14k | -2,37% |
| 2026-04-02 | Mr. Travis ThompsonCFO | -901,00 | 4,44k | Vendita | 4,91 - 5,05 | 7,90k | -10,24% |
| 2026-04-02 | Dr. Michael Charles-Ferguson HannayChief Product & Supply Chain Officer | -1,77k | 8,74k | Vendita | 4,91 - 5,05 | 13,54k | -11,58% |
| 2026-04-02 | Dr. Michael SkynnerChief Scientific Officer | -2,40k | 11,88k | Vendita | 4,91 - 5,05 | 69,97k | -3,32% |
| 2026-04-06 | Dr. Jennifer PerryCOO | -333,00 | 1,68k | Automatic Disposition | 5,04 | 92,46k | -0,36% |
| 2026-04-02 | Dr. Jennifer PerryCOO | -1,08k | 5,28k | Vendita | 4,91 - 5,05 | 92,46k | -1,15% |
| 2026-01-02 | Ms. Alethia Rene YoungInsider | -5,75k | 38,21k | Vendita | 6,45 - 6,80 | 4,83k | -54,32% |
| 2026-01-05 | Ms. Alethia Rene YoungInsider | -1,88k | 12,28k | Automatic Disposition | 6,54 | 4,83k | -27,99% |
| 2026-01-02 | Dr. Kevin LeeCEO & Executive Director | -21,31k | 141,20k | Vendita | 6,46 - 6,80 | 308,72k | -6,46% |
| 2026-01-02 | Dr. Michael Charles-Ferguson HannayChief Product & Supply Chain Officer | -5,19k | 34,49k | Vendita | 6,45 - 6,80 | 11,61k | -30,91% |
| 2026-01-02 | Mr. Alistair MilnesChief Corporate Development Officer | -6,66k | 44,13k | Vendita | 6,46 - 6,80 | 36,59k | -15,40% |
| 2026-01-02 | Dr. Michael SkynnerChief Scientific Officer | -6,31k | 41,80k | Vendita | 6,46 - 6,80 | 67,34k | -8,57% |
| 2026-01-02 | Mr. Travis ThompsonCFO | -2,43k | 16,15k | Vendita | 6,45 - 6,80 | 6,39k | -27,57% |
| 2025-10-02 | Ms. Alethia Rene YoungInsider | -217,00 | 1,82k | Vendita | 8,40 | 2,95k | -6,84% |
| 2025-10-02 | Ms. Alethia Rene YoungInsider | -265,00 | 2,28k | Automatic Disposition | 8,61 | 2,95k | -8,23% |
| 2025-10-02 | Mr. Travis ThompsonCFO | -324,00 | 2,72k | Vendita | 8,40 - 8,41 | 4,70k | -6,45% |
| 2025-10-02 | Dr. Robert Charles SwantonDirector & Member of Clinical Advisory Board | -102,00 | 872,10 | Automatic Disposition | 8,55 | 581,00 | -14,93% |
| 2025-10-02 | Dr. Michael SkynnerChief Scientific Officer | -1,80k | 15,15k | Vendita | 8,40 - 8,41 | 61,12k | -2,86% |
| 2025-10-02 | Dr. Kevin LeeCEO & Executive Director | -5,49k | 46,18k | Vendita | 8,40 - 8,41 | 287,70k | -1,87% |
| 2025-10-02 | Dr. Michael Charles-Ferguson HannayChief Product & Supply Chain Officer | -723,00 | 6,08k | Vendita | 8,40 - 8,41 | 6,54k | -9,96% |
| 2025-10-02 | Mr. Alistair MilnesChief Corporate Development Officer | -2,13k | 17,86k | Vendita | 8,40 - 8,41 | 30,03k | -6,61% |
| 2025-07-02 | Mr. Travis ThompsonCFO | -306,00 | 2,20k | Vendita | 7,09 - 7,44 | 31,52k | -0,96% |
| 2025-07-02 | Dr. Michael Charles-Ferguson HannayChief Product & Supply Chain Officer | -722,00 | 5,21k | Vendita | 7,09 - 7,44 | 5,24k | -12,11% |
| 2025-07-02 | Mr. Alistair MilnesChief Corporate Development Officer | -2,12k | 15,33k | Vendita | 7,09 - 7,44 | 27,69k | -7,10% |
| 2025-07-02 | Dr. Michael SkynnerChief Scientific Officer | -1,79k | 13,04k | Vendita | 7,09 - 7,44 | 59,14k | -2,94% |
| 2025-07-02 | Dr. Kevin LeeCEO & Executive Director | -5,46k | 39,84k | Vendita | 7,09 - 7,44 | 281,67k | -1,90% |
| 2025-07-02 | Ms. Alethia Rene YoungInsider | -204,00 | 1,45k | Vendita | 7,09 | 2,69k | -7,06% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
